PHARMA PLUS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA PLUS
Largest movements
- Receivables within one year -€26,725
down €26,725 (-3.8%), from €702,216 to €675,491
of which Trade receivables: -€16,525
- Tangible fixed assets +€11,764
up €11,764 (+5.0%), from €234,709 to €246,473
of which Furniture and vehicles: +€14,220
- Trade debts -€35,307
down €35,307 (-25.2%), from €140,001 to €104,694
- Reserves +€15,884
up €15,884 (+2.0%), from €798,154 to €814,038
of which Distributable reserves: +€15,884
- Gross operating margin -€354,597
down €354,597 (-58.8%), from €602,949 to €248,353
- Depreciation -€279,899
down €279,899 (-95.9%), from €291,762 to €11,862
- Taxes -€22,766
down €22,766 (-74.2%), from €30,695 to €7,929
- Staff costs +€8,921
up €8,921 (+4.3%), from €207,485 to €216,406
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,049,272 | €1,028,341 | -€20,931 | -2.0% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €234,709 | €246,473 | +€11,764 | +5.0% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €234,709 | €246,473 | +€11,764 | +5.0% |
| Land and buildings | 22 | €217,529 | €219,725 | +€2,196 | +1.0% |
| Plant, machinery and equipment | 23 | €15,675 | €11,023 | -€4,652 | -29.7% |
| Furniture and vehicles | 24 | €1,505 | €15,725 | +€14,220 | +945% |
| Current assets | 29/58 | €814,563 | €781,868 | -€32,695 | -4.0% |
| Stocks and contracts in progress | 3 | €103,276 | €101,001 | -€2,274 | -2.2% |
| Stocks | 30/36 | €103,276 | €101,001 | -€2,274 | -2.2% |
| Amounts receivable within one year | 40/41 | €702,216 | €675,491 | -€26,725 | -3.8% |
| Trade receivables | 40 | €122,898 | €106,373 | -€16,525 | -13.4% |
| Other amounts receivable | 41 | €579,319 | €569,118 | -€10,200 | -1.8% |
| Cash at bank and in hand | 54/58 | €5,478 | €5,375 | -€103 | -1.9% |
| Deferred charges and accrued income | 490/1 | €3,593 | - | -€3,593 | |
| Total equity and liabilities | 10/49 | €1,049,272 | €1,028,341 | -€20,931 | -2.0% |
| Equity | 10/15 | €860,154 | €876,038 | +€15,884 | +1.8% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €798,154 | €814,038 | +€15,884 | +2.0% |
| Tax-exempt reserves | 132 | €131,250 | €131,250 | = | 0.0% |
| Distributable reserves | 133 | €666,904 | €682,788 | +€15,884 | +2.4% |
| Amounts payable | 17/49 | €189,118 | €152,303 | -€36,815 | -19.5% |
| Amounts payable within one year | 42/48 | €189,118 | €152,303 | -€36,815 | -19.5% |
| Trade debts | 44 | €140,001 | €104,694 | -€35,307 | -25.2% |
| Suppliers | 440/4 | €140,001 | €104,694 | -€35,307 | -25.2% |
| Taxes, remuneration and social security | 45 | €49,117 | €47,609 | -€1,508 | -3.1% |
| Taxes | 450/3 | €20,999 | €20,695 | -€304 | -1.4% |
| Remuneration and social security | 454/9 | €28,118 | €26,914 | -€1,204 | -4.3% |
| Non-recurring operating income | 76A | €350,000 | - | -€350,000 | |
| Remuneration, social security and pensions | 62 | €207,485 | €216,406 | +€8,921 | +4.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €291,762 | €11,862 | -€279,899 | -95.9% |
| Other operating charges | 640/8 | €8,489 | €8,008 | -€481 | -5.7% |
| Gross operating margin | 9900 | €602,949 | €248,353 | -€354,597 | -58.8% |
| Operating profit (loss) | 9901 | €95,214 | €12,076 | -€83,138 | -87.3% |
| Financial income | 75/76B | €19,450 | €16,749 | -€2,701 | -13.9% |
| Recurring financial income | 75 | €19,450 | €16,749 | -€2,701 | -13.9% |
| Financial charges | 65/66B | €5,617 | €5,012 | -€605 | -10.8% |
| Recurring financial charges | 65 | €5,617 | €5,012 | -€605 | -10.8% |
| Profit (loss) for the period before taxes | 9903 | €109,047 | €23,813 | -€85,234 | -78.2% |
| Income taxes | 67/77 | €30,695 | €7,929 | -€22,766 | -74.2% |
| Profit (loss) for the period | 9904 | €78,352 | €15,884 | -€62,468 | -79.7% |
| Profit (loss) for the period to be appropriated | 9905 | €78,352 | €15,884 | -€62,468 | -79.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.